You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 7, July 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Surgical Interventions, Other
 •Alert me on articles by topic

The Clinical Implications of Hypophosphatemia Following Major Hepatic Resection or Cryosurgery

Joseph F. Buell, MD; Adam C. Berger, MD; Jeffrey S. Plotkin, MD; Paul C. Kuo, MD; Lynt B. Johnson, MD

Arch Surg. 1998;133:757-761.

Objectives  To determine the incidence and predisposing factors leading to postoperative hypophosphatemia after major hepatic surgery and the consequences of this electrolyte abnormality.

Design  A retrospective study.

Setting  A university tertiary care referral center.

Patients and Methods  Thirty-five consecutive patients undergoing either major hepatic resections or cryosurgery from July 1994 through January 1997 were retrospectively reviewed for the occurrence of hypophosphatemia and postoperative complications.

Main Outcome Measures  Prolonged ventilatory support, intensive care unit and hospital stays, and the incidence of postoperative complications.

Results  The overall incidence of hypophosphatemia in our series was 21 (67%) of 35 with a mortality rate of 1 (2.8%) in 35. Mean operative time, estimated blood loss, partial vascular occlusion time, and transfusion requirements were similar between the hypophosphatemic and the nonhypophosphatemic groups. The presence of postoperative complications was significantly greater in the hypophosphatemic group (17 [80] of 21) vs the nonhypophosphatemic group (4 [28] of 14) (P<.05). The incidence of antacid use in the hypophosphatemic group (14 [66] of 21) was significantly higher than the use in the nonhypophosphatemic group (2 [14] of 14) (P<.05).

Conclusions  Hypophosphatemia commonly occurs in major hepatic procedures. The presence of moderate hypophosphatemia is associated with the use of antacid therapy but no other perioperative or operative variables. The occurrence of hypophosphatemia correlates with an increased incidence of postoperative complications. Awareness of this entity can direct aggressive replacement of phosphates and avert the occurrence of severe hypophosphatemia and associated complications.


From the Department of Surgery, University of Maryland School of Medicine, Baltimore (Drs Buell and Berger) and the Departments of Anesthesiology (Dr Plotkin) and Surgery (Drs Kuo and Johnson), Georgetown University School of Medicine, Washington, DC.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hypophosphatemia following open heart surgery: incidence and consequences
Cohen et al.
Eur. J. Cardiothorac. Surg. 2004;26:306-310.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.